groupH
  • About Us
    • How We Work With You
    • Values
    • History
  • Team
  • Services
    • Decisions We Inform
    • Forecasting Event
  • Tools
    • PEAK SHARE 360 Suite
      • APEX Tool (beta)
      • SCORE Tool
      • REAL (coming soon)
      • Devil’s Advocate Tool
    • US PRICING Suite
      • US Pricing Tool
      • Gross-to-Net Tool (US)
      • Inflation Reduction Act (IRA) Tool
      • MAPPI Tool
    • Forecasting Support
      • Early-Stage Forecasting Tool (coming soon)
  • Our Work
    • view by Therapy Area
    • view by Our Services
  • How We Work
  • Clients
  • Insights
  • News & Events
  • Careers
  • Contact Us
  • Menu Menu
groupH

About groupH

This author has not written his bio yet.
But we are proud to say that groupH contributed 44 entries already.

Entries by groupH

groupH explored the NEEDS in the Early-Space through an internal qualitative study involving 15 in-depth interviews with Early-Space specialists in large Pharma, midcap and biotech organisations.

31st May 2026/in Interview

groupH explored the NEEDS in the Early-Space through an internal qualitative study involving 15 in-depth interviews with Early-Space specialists in large Pharma, midcap and biotech organisations. Download PDF

Understanding China’s Oncology Care: What Primary Research Reveals Beyond Secondary Data

28th May 2026/in White Papers

Insights from groupH’s physician network across China – uncovering what truly drives patient and physician behaviour in oncology. Download PDF

Enjoying the now and looking forward to 2026

18th December 2025/in News

Dear clients, groupH associates and collaborators, Much has been done and achieved. I am sure you are all looking forward to take a deep breath and to close a busy year by spending the time together with your family, loved ones and friends. I am very proud of all the work accomplished over the last […]

2025: groupH remains carbon neutral

29th August 2025/in News

For many of us, the world of work changed due to COVID-19, with carbon-saving remote working becoming the norm wherever possible. Since its inception in 2005, groupH has consistently embraced a virtual working model helping to keep emissions to a minimum. In 2025, we continue to offset our already small annual carbon output. This year, […]

Introducing Joy Mabon and groupH Inc.

2nd June 2017/in News

groupH is pleased to announce that Joy Mabon has joined our core team.  She has been a valued colleague for a long time, and is now officially one of us. Joy is a consultant with many years of experience designing and facilitating bespoke strategy workshops to support biopharmaceutical decision-making across a broad range of therapeutic […]

Transforming trial design and positioning for novel oncology therapy

5th May 2017/in Oncology, TPP shaping and validation

Rare and Orphan Diseases, Gene and Cell Therapy

5th May 2017/in Uncategorised

Demand Assessment and Attribute Testing in Neuropathic Pain

5th May 2017/in CNS, Demand assessments

Multiple waves of in-depth market research to support the commercial forecast assumptions for a novel antibiotic used to treat Gram negative infections

5th May 2017/in Demand assessments, Infectious Disesases

Breast Cancer Strategic Gaming Workshop to understand fit of developmental product into future treatment landscape

5th May 2017/in Competitor workshops, Oncology
Page 1 of 512345

Pages

  • Devil’s Advocate Tool
  • Download Form
  • Download270319
  • Gross-to-Net (US) Tool
  • History
  • Home
  • Inflation Reduction Act Tool
  • Peak Share Analogue Tool
  • Peak Share Tool
  • Tools
  • US Pricing Tool
  • About Us
  • Decisions We Inform
  • How We Work With You
  • Therapy Area
  • Service Offering
  • Team
  • Values
  • Forecasting Event
  • Services
  • MAPPI Tool
  • Our Work
  • Clients
  • How We Work
  • Our Insights
  • News & Events
  • Contact us
  • Register
  • Careers
  • Cookie Policy
  • Privacy Policy
  • Sitemap
  • Terms & Conditions
  • Training Terms & Conditions

Categories

  • Autoimmune
  • Briefing Note
  • Careers
  • CNS
  • Comment
  • Competitor workshops
  • Demand assessments
  • Dermatology
  • Disease area strategy
  • Events
  • Infectious Disesases
  • Inspiration
  • Interview
  • Market landscaping
  • New Horizons
  • News
  • Oncology
  • Scenario planning workshops
  • Team
  • TPP shaping and validation
  • Uncategorised
  • White Papers

Archive

  • May 2026
  • December 2025
  • August 2025
  • April 2025
  • February 2025
  • December 2024
  • October 2024
  • September 2024
  • June 2024
  • May 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • July 2023
  • June 2023
  • February 2023
  • December 2022
  • November 2022
  • October 2022
  • July 2022
  • April 2022
  • January 2022
  • October 2021
  • September 2021
  • August 2021
  • June 2021
  • May 2021
  • January 2021
  • December 2020
  • October 2020
  • June 2020
  • May 2020
  • December 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • March 2019
  • December 2018
  • September 2018
  • August 2018
  • May 2018
  • December 2017
  • October 2017
  • September 2017
  • June 2017
  • May 2017
  • December 2016
  • November 2016
  • October 2016
  • May 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • June 2015
  • April 2015
  • March 2015
  • December 2014
  • September 2014
  • November 2013
  • July 2013
  • June 2013
  • April 2013
  • March 2013
  • February 2013
  • December 2012
  • November 2012
  • September 2012
  • February 2012
  • December 2010

© groupH Ltd

LinkedIn
newsletter
Vimeo

  • Contact us
  • Tools
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Sitemap
Scroll to top Scroll to top Scroll to top
By continuing to use this website you will be agreeing to our Terms & Conditions, our Privacy Policy, and the use of cookies.